NO982976L - N-acylaminoalkylhydrazinkarboksimidamider - Google Patents

N-acylaminoalkylhydrazinkarboksimidamider

Info

Publication number
NO982976L
NO982976L NO982976A NO982976A NO982976L NO 982976 L NO982976 L NO 982976L NO 982976 A NO982976 A NO 982976A NO 982976 A NO982976 A NO 982976A NO 982976 L NO982976 L NO 982976L
Authority
NO
Norway
Prior art keywords
carbon atoms
composition
group containing
inhibiting
protein
Prior art date
Application number
NO982976A
Other languages
English (en)
Norwegian (no)
Other versions
NO982976D0 (no
Inventor
Peter C Ulrich
Dilip R Wagle
Original Assignee
Alteon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/771,959 external-priority patent/US5877217A/en
Application filed by Alteon Inc filed Critical Alteon Inc
Publication of NO982976D0 publication Critical patent/NO982976D0/no
Publication of NO982976L publication Critical patent/NO982976L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Fats And Perfumes (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)
NO982976A 1995-12-26 1998-06-26 N-acylaminoalkylhydrazinkarboksimidamider NO982976L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US922095P 1995-12-26 1995-12-26
US61840796A 1996-03-19 1996-03-19
US08/771,959 US5877217A (en) 1995-12-26 1996-12-23 N-acylaminoalkyl-hydrazinecarboximidamides
PCT/US1996/020810 WO1997023447A1 (en) 1995-12-26 1996-12-26 N-acylaminoalkylhydrazinecarboximidamides

Publications (2)

Publication Number Publication Date
NO982976D0 NO982976D0 (no) 1998-06-26
NO982976L true NO982976L (no) 1998-08-26

Family

ID=27358809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982976A NO982976L (no) 1995-12-26 1998-06-26 N-acylaminoalkylhydrazinkarboksimidamider

Country Status (15)

Country Link
EP (1) EP0888293B1 (es)
JP (1) JP2000502684A (es)
CN (1) CN1209117A (es)
AT (1) ATE215068T1 (es)
AU (1) AU720796B2 (es)
BR (1) BR9612304A (es)
CA (1) CA2241746A1 (es)
DE (1) DE69620253T2 (es)
DK (1) DK0888293T3 (es)
ES (1) ES2174132T3 (es)
NO (1) NO982976L (es)
NZ (1) NZ326238A (es)
PT (1) PT888293E (es)
TW (1) TW502012B (es)
WO (1) WO1997023447A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR102668834B1 (ko) 2009-11-27 2024-05-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
ES2935300T3 (es) 2010-05-05 2023-03-03 Boehringer Ingelheim Int Combiterapia
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EA030121B1 (ru) 2011-07-15 2018-06-29 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные хиназолины, их получение и их применение в фармацевтических композициях
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging

Also Published As

Publication number Publication date
NZ326238A (en) 1999-11-29
EP0888293B1 (en) 2002-03-27
TW502012B (en) 2002-09-11
DE69620253T2 (de) 2002-09-19
AU720796B2 (en) 2000-06-15
JP2000502684A (ja) 2000-03-07
CA2241746A1 (en) 1997-07-03
PT888293E (pt) 2002-07-31
WO1997023447A1 (en) 1997-07-03
AU1356097A (en) 1997-07-17
ATE215068T1 (de) 2002-04-15
DK0888293T3 (da) 2002-04-22
NO982976D0 (no) 1998-06-26
CN1209117A (zh) 1999-02-24
EP0888293A1 (en) 1999-01-07
ES2174132T3 (es) 2002-11-01
DE69620253D1 (en) 2002-05-02
BR9612304A (pt) 1999-07-13

Similar Documents

Publication Publication Date Title
NO982976L (no) N-acylaminoalkylhydrazinkarboksimidamider
ATE112165T1 (de) Verfahren und mittel zur hemmung des proteinveraltens.
WO1993014750A3 (en) Amino acids useful as inhibitors of the advanced glycosylation of proteins
RU94046295A (ru) L-аспартил-d- альфа -аминоалканоил-(s)-n-d-алкилбензиламиды, используемые в качестве искусственных подслащивающих агентов, пищевой состав, способ подслащивания пищевого состава
NZ312840A (en) Ketoheterocyclic inhibitors of factor Xa
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
HK1039488A1 (en) Tricylic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases.
EP0316852A3 (en) Inhibitors of nonenzymatic cross-linking
RU97105363A (ru) Жидкие иммуноглобулиновые препараты
MY135057A (en) Dolastatin 15 derivatives
EA199800773A1 (ru) Производные пирролопирролона в качестве ингибиторов нейтрофильной эластазы
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
EA199800378A1 (ru) Новый способ получения фенилимидазолидиновых производных
AU3895689A (en) Cyclic sulfur-containing amino acid derivatives
WO1996021450A3 (en) Bis-[hydrazones]
DE69718775D1 (de) 1,2,4-triazinderivate zur inhibierung der proteinglycosylierung
AU2825897A (en) Substituted imidazolium salts and their use for the inhibition of protein ageing
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
BR8303032A (pt) Sililoxialcano-azois, processo para sua preparacao, composicoes praguicidas, processo para o combate ou protecao de uma infestacao por microorganismo e processo para a preparacao de uma composicao
RU95117692A (ru) Щелочные соли амидов оротовой кислоты и аминокислот, обладающие гипертензивной активностью
PT835265E (pt) Inibidores da agregacao plaquetaria contendo residuos de aminoacidos de cadeia lateral aminergica c-terminal
DE69622393D1 (de) Neue verwendung von pyrazolopyridinverbindungen
RU94035756A (ru) Производные имидазола, являющиеся ингибиторами питокинов, способы их получения, фармацевтическая композиция